Distinct narcolepsy syndromes in orexin receptor-2 and orexin null mice: Molecular genetic dissection of non-REM and REM sleep regulatory processes

Jon T. Willie, Richard M. Chemelli, Christopher M. Sinton, Shigeru Tokita, S. Clay Williams, Yaz Y. Kisanuki, Jacob N. Marcus, Charlotte Lee, Joel K Elmquist, Kristi A. Kohlmeier, Christopher S. Leonard, James A Richardson, Robert E Hammer, Masashi Yanagisawa

Research output: Contribution to journalArticle

457 Citations (Scopus)

Abstract

Narcolepsy-cataplexy, a neurological disorder associated with the absence of hypothalamic orexin (hypocretin) neuropeptides, consists of two underlying problems: inability to maintain wakefulness and intrusion of rapid eye movement (REM) sleep into wakefulness. Here we document, using behavioral, electrophysiological, and pharmacological criteria, two distinct classes of behavioral arrests exhibited by mice deficient in orexin-mediated signaling. Both OX2R-/- and orexin-/- mice are similarly affected with behaviorally abnormal attacks of non-REM sleep ("sleep attacks") and show similar degrees of disrupted wakefulness. In contrast, OX2R-/- mice are only mildly affected with cataplexy-like attacks of REM sleep, whereas orexin-/- mice are severely affected. Absence of OX2Rs eliminates orexin-evoked excitation of histaminergic neurons in the hypothalamus, which gate non-REM sleep onset. While normal regulation of wake/non-REM sleep transitions depends critically upon OX2R activation, the profound dysregulation of REM sleep control unique to the narcolepsy-cataplexy syndrome emerges from loss of signaling through both OX2R-dependent and OX2R-independent pathways.

Original languageEnglish (US)
Pages (from-to)715-730
Number of pages16
JournalNeuron
Volume38
Issue number5
DOIs
StatePublished - Jun 5 2003

Fingerprint

Orexin Receptors
Narcolepsy
REM Sleep
Eye Movements
Dissection
Molecular Biology
Sleep
Wakefulness
Cataplexy
Nervous System Diseases
Neuropeptides
Hypothalamus
Pharmacology
Neurons

ASJC Scopus subject areas

  • Neuroscience(all)

Cite this

Distinct narcolepsy syndromes in orexin receptor-2 and orexin null mice : Molecular genetic dissection of non-REM and REM sleep regulatory processes. / Willie, Jon T.; Chemelli, Richard M.; Sinton, Christopher M.; Tokita, Shigeru; Williams, S. Clay; Kisanuki, Yaz Y.; Marcus, Jacob N.; Lee, Charlotte; Elmquist, Joel K; Kohlmeier, Kristi A.; Leonard, Christopher S.; Richardson, James A; Hammer, Robert E; Yanagisawa, Masashi.

In: Neuron, Vol. 38, No. 5, 05.06.2003, p. 715-730.

Research output: Contribution to journalArticle

Willie, Jon T. ; Chemelli, Richard M. ; Sinton, Christopher M. ; Tokita, Shigeru ; Williams, S. Clay ; Kisanuki, Yaz Y. ; Marcus, Jacob N. ; Lee, Charlotte ; Elmquist, Joel K ; Kohlmeier, Kristi A. ; Leonard, Christopher S. ; Richardson, James A ; Hammer, Robert E ; Yanagisawa, Masashi. / Distinct narcolepsy syndromes in orexin receptor-2 and orexin null mice : Molecular genetic dissection of non-REM and REM sleep regulatory processes. In: Neuron. 2003 ; Vol. 38, No. 5. pp. 715-730.
@article{cdaa7eee39744d758802345566f5616d,
title = "Distinct narcolepsy syndromes in orexin receptor-2 and orexin null mice: Molecular genetic dissection of non-REM and REM sleep regulatory processes",
abstract = "Narcolepsy-cataplexy, a neurological disorder associated with the absence of hypothalamic orexin (hypocretin) neuropeptides, consists of two underlying problems: inability to maintain wakefulness and intrusion of rapid eye movement (REM) sleep into wakefulness. Here we document, using behavioral, electrophysiological, and pharmacological criteria, two distinct classes of behavioral arrests exhibited by mice deficient in orexin-mediated signaling. Both OX2R-/- and orexin-/- mice are similarly affected with behaviorally abnormal attacks of non-REM sleep ({"}sleep attacks{"}) and show similar degrees of disrupted wakefulness. In contrast, OX2R-/- mice are only mildly affected with cataplexy-like attacks of REM sleep, whereas orexin-/- mice are severely affected. Absence of OX2Rs eliminates orexin-evoked excitation of histaminergic neurons in the hypothalamus, which gate non-REM sleep onset. While normal regulation of wake/non-REM sleep transitions depends critically upon OX2R activation, the profound dysregulation of REM sleep control unique to the narcolepsy-cataplexy syndrome emerges from loss of signaling through both OX2R-dependent and OX2R-independent pathways.",
author = "Willie, {Jon T.} and Chemelli, {Richard M.} and Sinton, {Christopher M.} and Shigeru Tokita and Williams, {S. Clay} and Kisanuki, {Yaz Y.} and Marcus, {Jacob N.} and Charlotte Lee and Elmquist, {Joel K} and Kohlmeier, {Kristi A.} and Leonard, {Christopher S.} and Richardson, {James A} and Hammer, {Robert E} and Masashi Yanagisawa",
year = "2003",
month = "6",
day = "5",
doi = "10.1016/S0896-6273(03)00330-1",
language = "English (US)",
volume = "38",
pages = "715--730",
journal = "Neuron",
issn = "0896-6273",
publisher = "Cell Press",
number = "5",

}

TY - JOUR

T1 - Distinct narcolepsy syndromes in orexin receptor-2 and orexin null mice

T2 - Molecular genetic dissection of non-REM and REM sleep regulatory processes

AU - Willie, Jon T.

AU - Chemelli, Richard M.

AU - Sinton, Christopher M.

AU - Tokita, Shigeru

AU - Williams, S. Clay

AU - Kisanuki, Yaz Y.

AU - Marcus, Jacob N.

AU - Lee, Charlotte

AU - Elmquist, Joel K

AU - Kohlmeier, Kristi A.

AU - Leonard, Christopher S.

AU - Richardson, James A

AU - Hammer, Robert E

AU - Yanagisawa, Masashi

PY - 2003/6/5

Y1 - 2003/6/5

N2 - Narcolepsy-cataplexy, a neurological disorder associated with the absence of hypothalamic orexin (hypocretin) neuropeptides, consists of two underlying problems: inability to maintain wakefulness and intrusion of rapid eye movement (REM) sleep into wakefulness. Here we document, using behavioral, electrophysiological, and pharmacological criteria, two distinct classes of behavioral arrests exhibited by mice deficient in orexin-mediated signaling. Both OX2R-/- and orexin-/- mice are similarly affected with behaviorally abnormal attacks of non-REM sleep ("sleep attacks") and show similar degrees of disrupted wakefulness. In contrast, OX2R-/- mice are only mildly affected with cataplexy-like attacks of REM sleep, whereas orexin-/- mice are severely affected. Absence of OX2Rs eliminates orexin-evoked excitation of histaminergic neurons in the hypothalamus, which gate non-REM sleep onset. While normal regulation of wake/non-REM sleep transitions depends critically upon OX2R activation, the profound dysregulation of REM sleep control unique to the narcolepsy-cataplexy syndrome emerges from loss of signaling through both OX2R-dependent and OX2R-independent pathways.

AB - Narcolepsy-cataplexy, a neurological disorder associated with the absence of hypothalamic orexin (hypocretin) neuropeptides, consists of two underlying problems: inability to maintain wakefulness and intrusion of rapid eye movement (REM) sleep into wakefulness. Here we document, using behavioral, electrophysiological, and pharmacological criteria, two distinct classes of behavioral arrests exhibited by mice deficient in orexin-mediated signaling. Both OX2R-/- and orexin-/- mice are similarly affected with behaviorally abnormal attacks of non-REM sleep ("sleep attacks") and show similar degrees of disrupted wakefulness. In contrast, OX2R-/- mice are only mildly affected with cataplexy-like attacks of REM sleep, whereas orexin-/- mice are severely affected. Absence of OX2Rs eliminates orexin-evoked excitation of histaminergic neurons in the hypothalamus, which gate non-REM sleep onset. While normal regulation of wake/non-REM sleep transitions depends critically upon OX2R activation, the profound dysregulation of REM sleep control unique to the narcolepsy-cataplexy syndrome emerges from loss of signaling through both OX2R-dependent and OX2R-independent pathways.

UR - http://www.scopus.com/inward/record.url?scp=0038724250&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0038724250&partnerID=8YFLogxK

U2 - 10.1016/S0896-6273(03)00330-1

DO - 10.1016/S0896-6273(03)00330-1

M3 - Article

C2 - 12797957

AN - SCOPUS:0038724250

VL - 38

SP - 715

EP - 730

JO - Neuron

JF - Neuron

SN - 0896-6273

IS - 5

ER -